US Stock MarketDetailed Quotes

CYCC Cyclacel Pharmaceuticals

Watchlist
  • 0.4151
  • -0.0270-6.11%
Close Nov 6 16:00 ET
  • 0.4170
  • +0.0019+0.46%
Post 17:31 ET
892.93KMarket Cap-27P/E (TTM)

Cyclacel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cyclacel Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2024/Q4 -- / 10.000K --
-- 2024/Q3 -- / 10.000K --
Aug 14, 2024 2024/Q2 4.000K / 15.000K --
May 14, 2024 2024/Q1 29.000K / 0.000 --
Mar 19, 2024 2023/Q4 31.000K / 0.000 --
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 10.000K--
--2024/Q3-- / 10.000K--
Aug 14, 20242024/Q24.000K / 15.000K--
May 14, 20242024/Q129.000K / 0.000--
Mar 19, 20242023/Q431.000K / 0.000--

Unlock Free Earnings Estimates

Cyclacel Pharmaceuticals Earnings Reports

  • 10-Q: Q2 2024 Earnings Report

    Aug 15 05:10

  • 10-Q: Q1 2024 Earnings Report

    May 15 05:16

  • 10-K/A: Annual report (Amendment)

    Apr 30 05:06

  • Cyclacel Pharmaceuticals | 10-K: FY2023 Annual Report

    Mar 22 05:07

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 6, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data